Tofacitinib Citrate Impurity 77 Hydrochloride
- CAS1228878-92-9
- CatalogueRS-T095067
- FormulaC8H16N2O2.HCl
- MW208.69
On this page
Product identification
| Product name | Tofacitinib Citrate Impurity 77 Hydrochloride |
|---|---|
| Catalogue No. | RS-T095067 |
| CAS No. | 1228878-92-9 |
| Molecular formula | C8H16N2O2.HCl |
| Molecular weight | 208.69 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Tofacitinib Citrate |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-T095067 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Tofacitinib Citrate
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-T095067
- Request a quotation for RS-T095067
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Tofacitinib Citrate
All 80 further standards are listed here — every link is in the page, not loaded later.
-
Tofacitinib Citrate
IN STOCKRS-I013035 -
(-)-O,O'-di-p-Toluoyl-L-tartaric Acid
IN STOCKRS-Z412Q11 -
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine
IN STOCKRS-Z412QXI -
(3R,4R)-1-Benzyl-N-ethyl-4-methylpiperidin-3-amine
BACK ORDERRS-Z401HOA -
(3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine
CUSTOM SYNTHESISRS-Z412MT6 -
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine
CUSTOM SYNTHESISRS-P006150 -
3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol
BACK ORDERRS-Z001PNA -
3-Hydroxypropionitrile
IN STOCKRS-C007006 -
4,6-dichloro-7H-pyrrolo[2,3-d]pyrimidine
IN STOCKRS-C002218 -
7H-pyrrolo[2,3-d]pyrimidine-2,4-diol
IN STOCKRS-P030017 -
N-Hydroxysulfosuccinimide Sodium Salt
IN STOCKRS-U054022 -
TSTU
CUSTOM SYNTHESISRS-U016061 -
Tofacitinib Citrate Impurity 2 Dihydrochloride
IN STOCKRS-Z401CUJ -
Tofacitinib Citrate Impurity 6
IN STOCKRS-T095063 -
Tofacitinib Citrate Impurity 10
CUSTOM SYNTHESISRS-T095035 -
Tofacitinib Citrate Impurity 22
BACK ORDERRS-T095016 -
Tofacitinib Citrate Impurity 26 (Mixture of Enantiomers)
IN STOCKRS-Z412PHQ -
Tofacitinib Citrate Impurity 36
IN STOCKRS-T095049 -
Tofacitinib Citrate Impurity 38 Monomer
IN STOCKRS-I009055 -
Tofacitinib Citrate Impurity 39 Monomer
CUSTOM SYNTHESISRS-U009113 -
Tofacitinib Citrate Impurity 41
IN STOCKRS-T095033 -
Tofacitinib Citrate Impurity 49
BACK ORDERRS-T095018 -
Tofacitinib Citrate Impurity 53 Monomer
IN STOCKRS-T095021 -
Tofacitinib Citrate Impurity 60
CUSTOM SYNTHESISRS-T095008 -
Tofacitinib Citrate Impurity 84
BACK ORDERRS-T095034 -
Tofacitinib Citrate Impurity 101
CUSTOM SYNTHESISRS-T095025 -
Tofacitinib Citrate Impurity 102
IN STOCKRS-T095027 -
Tofacitinib Citrate Impurity 118
BACK ORDERRS-T095041 -
Tofacitinib Citrate Impurity 122
IN STOCKRS-T095012 -
Tofacitinib Citrate Impurity 132
IN STOCKRS-T095011 -
Tofacitinib Citrate Impurity 144
IN STOCKRS-T095036 -
Tofacitinib Citrate Impurity 151
CUSTOM SYNTHESISRS-U004039 -
Tofacitinib Citrate Impurity 153
IN STOCKRS-T095020 -
Tofacitinib Citrate Impurity 155
IN STOCKRS-T095045 -
Tofacitinib Citrate Impurity 168
IN STOCKRS-T095048 -
Tofacitinib Citrate Impurity 170
CUSTOM SYNTHESISRS-T095047 -
Tofacitinib Citrate Impurity 175
BACK ORDERRS-T095015 -
Tofacitinib Citrate Impurity 189
IN STOCKRS-T095022 -
Tofacitinib Citrate Impurity 189 Acetate
IN STOCKRS-T095065 -
Tofacitinib Citrate Impurity 192 Monomer
CUSTOM SYNTHESISRS-T095019 -
Tofacitinib Citrate Impurity 195
BACK ORDERRS-T095037 -
Tofacitinib Citrate Impurity 204
CUSTOM SYNTHESISRS-T095013 -
Tofacitinib Citrate Impurity 205
CUSTOM SYNTHESISRS-T095052 -
Tofacitinib Citrate Impurity 208
IN STOCKRS-T095046 -
Tofacitinib Citrate Impurity 214
IN STOCKRS-T095014 -
Tofacitinib Citrate Impurity 219
IN STOCKRS-T095054 -
Tofacitinib Citrate Impurity 220
IN STOCKRS-T095038 -
Tofacitinib Citrate Impurity 221
IN STOCKRS-T095017 -
Tofacitinib Citrate Impurity 222
IN STOCKRS-Z412TJ8 -
Tofacitinib Citrate Impurity 225
IN STOCKRS-T095005 -
Tofacitinib Citrate Impurity 230
BACK ORDERRS-T095032 -
Tofacitinib Citrate Impurity 232
IN STOCKRS-T095055 -
Tofacitinib Citrate Impurity 243
IN STOCKRS-T095056 -
Tofacitinib Citrate Impurity 245
IN STOCKRS-T095057 -
Tofacitinib Citrate Impurity 246
IN STOCKRS-T095006 -
Tofacitinib Citrate Impurity 253
IN STOCKRS-T095031 -
Tofacitinib Citrate Impurity 259
IN STOCKRS-T095058 -
Tofacitinib Citrate Impurity 263
IN STOCKRS-T095004 -
Tofacitinib Citrate Impurity 264
IN STOCKRS-T095039 -
Tofacitinib Citrate Impurity 265
CUSTOM SYNTHESISRS-T095040 -
Tofacitinib Citrate Impurity 266
IN STOCKRS-Z401ITJ -
Tofacitinib Citrate Impurity 268
IN STOCKRS-T095059 -
Tofacitinib Citrate Impurity 282
IN STOCKRS-T095030 -
Tofacitinib Citrate Impurity 283
IN STOCKRS-T095026 -
Tofacitinib Citrate Impurity 284
IN STOCKRS-T095060 -
Tofacitinib Citrate Impurity 286
IN STOCKRS-I002136 -
Tofacitinib Citrate Impurity 288
CUSTOM SYNTHESISRS-T095051 -
Tofacitinib Citrate Impurity 289 (N-Nitroso Tofacitinib Citrate Impurity 53)
IN STOCKRS-T095042 -
Tofacitinib Citrate Impurity 289 (N-Nitroso Tofacitinib Citrate Impurity 53)
IN STOCKRS-Z412PX0 -
Tofacitinib Citrate Impurity 302
CUSTOM SYNTHESISRS-Z396PGC -
Tofacitinib Citrate Impurity 304
IN STOCKRS-T095023 -
Tofacitinib Citrate Impurity 306
IN STOCKRS-T095050 -
Tofacitinib Citrate Impurity 307
IN STOCKRS-T095061 -
Tofacitinib Citrate Impurity 311
IN STOCKRS-T095029 -
Tofacitinib Citrate Impurity 313
CUSTOM SYNTHESISRS-T095007 -
Tofacitinib Citrate Impurity 314
IN STOCKRS-T095053 -
Tofacitinib Citrate Impurity 315
IN STOCKRS-T095028 -
Tofacitinib Citrate Impurity 326
BACK ORDERRS-T095062
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.


![Chemical structure of (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine](/structures/w4/SFJWJKDDYBNESX-SCZZXKLOSA-N.webp?v=8)



![Chemical structure of 2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine](/structures/w4/DTDGVNQSPAWHTH-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol](/structures/w4/AUJXLBOHYWTPFV-UHFFFAOYSA-N.webp?v=8)

![Chemical structure of 4,6-dichloro-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/CGTRULURZFVPIX-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 7H-pyrrolo[2,3-d]pyrimidine-2,4-diol](/structures/w4/HASUWNAFLUMMFI-UHFFFAOYSA-N.webp?v=8)

![Chemical structure of N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine Dihydrochloride](/structures/w4/JZRCEFVKGXWGDP-SFGLUTOSSA-N.webp?v=8)































































